14K
Downloads
53
Episodes
IPA’s What, Why & How podcast unravels the intricacies of pharmacy and healthcare law and regulation, from Congress to the Board of Pharmacy. Each month, IPA’s CEO, Kate Gainer, welcomes a special guest to explore WHAT changes occurred, WHY action was taken, and HOW these changes will impact pharmacy practice.
Episodes
Wednesday Nov 18, 2020
Wednesday Nov 18, 2020
Following the November 17 Board of Pharmacy meeting, IPA's Director of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss board action on the FDA’s memorandum of understanding regarding compounding, proposed rules impacting controlled substances and the PMP, and the Board’s legislative agenda.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.